Vyne Therapeutics Inc (NASDAQ:VYNE)
| 0.2637 Delayed Data As of Feb 03 |  +0.0047 / +1.81%Today’s Change | 0.11 Today|||52-Week Range 0.79 | +75.80% Year-to-Date |
Latest VYNE News | Press Releases
No recent news for Vyne Therapeutics Inc.
Today’s Trading
| Previous close | 0.26 |
| Today’s open | 0.26 |
| Day’s range | 0.26 - 0.26 |
| Volume | 1,160 |
| Average volume (3 months) | 912,842 |
| Market cap | $14.8M |
Data as of 3:52pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +81.93% |
| Earnings growth (this year) | +62.43% |
| Earnings growth (next 5 years) | -53.49% |
| Revenue growth (last year) | -29.71% |
| P/E ratio | NM |
| Price/Sales | 3.56 |
| Price/Book | 0.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARDSAridis Pharmaceutica... | 0.00 | 0.00% |
| NERVMinerva Neuroscience... | +0.39 | +15.48% |
| TTNPTitan Pharmaceutical... | 0.00 | 0.00% |
| NRBONeurobo Pharmaceutic... | 0.00 | 0.00% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 2, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $14.8M |
| Annual profit (last year) | -$73.3M |
| Net profit margin | -496.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
